API and parent drug

Cefteram

CAS 82547-58-8 · C16H17N9O5S2 · 1 related records

01API identity and structure

2D structurePubChem CID 6537431
2D structure: Cefteram, CAS 82547-58-8
Structure of Cefteram (CAS 82547-58-8). LazyChem record. Source identity: PubChem CID 6537431. Confirm the identifiers before analytical use.Download structure image
API / medicine nameCefteram
CAS RN82547-58-8
PubChem CID6537431
Molecular formulaC16H17N9O5S2
Molecular weight479.5 g/mol
IUPAC name(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(5-methyltetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Defined stereocentres2
Unassigned stereocentres0
SMILESCC1=NN(N=N1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O
InChINot listed
InChIKeyXSPUSVIQHBDITA-RKYNPMAHSA-N

02Stereochemistry

The published structure contains 2 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.

Defined stereocentres22D structure
Unassigned stereocentres02D structure
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 4Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

03Structural nitrosamine screen

Record-level resultNo candidate is published

No record-level structural candidate is currently published for this identity.

This result does not predict manufacturing conditions, formation, analytical findings or absence of risk. A process-specific assessment is required.

04India status for this compound

The result below applies only to this exact compound identity and CAS number.

NDPS / RCSNOT FOUND IN REVIEWED ENTRIESNo exact reviewed identity entry was found. Generic, class, analogue, salt and isomer provisions were not evaluated. Confirm the current official schedule before a regulatory decision.
SCOMETNOT FOUND IN REVIEWED CAS ENTRIESCAS 82547-58-8 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated.

06Sources